[Skip to Content]
[Skip to Content Landing]
Citations 0
Correspondence
October 2010

Adherence to Treatment: Still the Forgotten Variable

Author Affiliations
 

Copyright 2010 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2010

Arch Dermatol. 2010;146(10):1183-1184. doi:10.1001/archdermatol.2010.269

In a well-written, scholarly, evidenced-based analysis, Gelfand and Abuabara1 identified 3 major limitations of a trial of weight loss and low-dose cyclosporine to treat obese patients with psoriasis.2 The limitations included potential bias in assessment of disease severity, potential effect of dropouts, and failure to control for the direct effect of diet alone on cyclosporine pharmacodynamics. While these factors could have affected the results, another factor, adherence to treatment, should be considered.

×